STRS:TASEStrauss Group Ltd Analysis
Data as of 2026-07-29 - not real-time
$19.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: STRS is trading at $19.40, well below its 20‑day ($22.76), 50‑day ($26.31) and 200‑day ($26.23) simple moving averages, with an RSI of 16.9 indicating heavy oversold pressure. The MACD line sits beneath its signal (‑2.25 vs ‑2.12) and the histogram is negative, reinforcing a bearish momentum. Volume is decreasing, 30‑day volatility is extreme at 66%, and beta is modest (~0.64), suggesting the stock moves independently of the market but with large price swings. Support sits around $18.85, just a dollar below the current price, while resistance is near $29.10.
Fundamental & corporate events: Valuation metrics appear attractive – a trailing P/E of 7.3 versus an industry average of 33, and a P/B of 0.73 – yet the DCF fair‑value estimate of $124 is likely overstated because the company has announced a $5.00 per‑share liquidating distribution and plans to voluntarily delist from Nasdaq and deregister with the SEC. Revenue has fallen 24.8% year‑over‑year, operating margins are deeply negative, and debt ($160 M) far exceeds cash ($73.5 M). The recent $21.7 M net cash from the Jones Crossing retail sale provides short‑term liquidity but underscores the winding‑down nature of the business.
Fundamental & corporate events: Valuation metrics appear attractive – a trailing P/E of 7.3 versus an industry average of 33, and a P/B of 0.73 – yet the DCF fair‑value estimate of $124 is likely overstated because the company has announced a $5.00 per‑share liquidating distribution and plans to voluntarily delist from Nasdaq and deregister with the SEC. Revenue has fallen 24.8% year‑over‑year, operating margins are deeply negative, and debt ($160 M) far exceeds cash ($73.5 M). The recent $21.7 M net cash from the Jones Crossing retail sale provides short‑term liquidity but underscores the winding‑down nature of the business.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold technicals (RSI 16.9) may support a modest bounce
- Pending $5 per‑share liquidation distribution provides near‑term upside
- Support level at $18.85 limits downside risk in the short horizon
Medium Term
1–3 yearsCautious
Model confidence: 8/10
Key Factors
- Company is in liquidation; post‑distribution cash runway is limited
- Delisting and deregistration will erode market depth and price stability
- High volatility (66% 30‑day) and decreasing volume increase price uncertainty
Long Term
> 3 yearsCautious
Model confidence: 9/10
Key Factors
- No sustainable earnings or dividend outlook; operating losses persist
- Debt‑to‑equity at 45.6% and a 40% historic drawdown signal financial strain
- The business will cease operations, leaving only residual cash per share
Key Metrics & Analysis
Financial Health
Revenue Growth-24.80%
Profit Margin74.96%
P/E Ratio7.3
ROE6.24%
ROA-2.67%
Debt/Equity45.59
P/B Ratio0.7
Op. Cash Flow$-31996000
Free Cash Flow$83.2M
Industry P/E33.0
Technical Analysis
TrendNeutral
RSI16.9
Support$18.85
Resistance$29.10
MA 20$22.76
MA 50$26.31
MA 200$26.23
MACDBearish
VolumeDecreasing
Fear & Greed Index84.54
Valuation
Fair Value$124.06
GradeUndervalued
TypeValue
Risk Assessment
Beta0.64
Volatility66.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.